跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROCODIN SYRUP - HSA Drug Approval Details
Approvals
/
HSA
/
PROCODIN SYRUP
Approved
THERAPEUTIC
PROCODIN SYRUP
ICM PHARMA PTE. LTD. (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
Mar 28, 1990
Approval ID
09fb4980d00c9f48
Company
ICM PHARMA PTE. LTD. (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
09fb4980d00c9f48
Drug Name
PROCODIN SYRUP
Product Name
PROCODIN SYRUP
Approval Number
SIN04075P
Approval Date
1990-03-28
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05DA20
Atc Item Name
combinations
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Active Ingredients
CODEINE PHOSPHATE
9 mg/5 ml
PROMETHAZINE HCl
3.6 mg/5 ml
CODEINE PHOSPHATE
9 MG/5 ML
PROMETHAZINE HCL
3.6 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 28, 1990
Approval ID
09fb4980d00c9f48
Type
Therapeutic
Back to HSA Approvals